The purpose of this report is to provide practical assistance to actuaries on setting up Best Estimate assumptions for biometric risk. The scope of the report is incidence rates. For details beyond this scope, such as for using incidence rates to calculate Best Estimates of reserves, results or other metrics, and for methodologies to smooth and fit data, please refer to other relevant published material.
Multiple Sclerosis (MS) is a condition that has no cure but is manageable with prudent treatment. There are approximately 950,000 cases of MS in the […]